Intra Cellular Therapies Inc Net Income per Employee (ITCI), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Intra cellular Therapies Inc   (NASDAQ: ITCI)
 

Intra Cellular Therapies Inc Net Income per Employee

ITCI's Quarterly Results, Trends, Rankings, Statistics
Intra Cellular Therapies Inc recorded a cumulative net loss of $-75 million during 12 month ending in the fourth quarter 2024.
The Healthcare sector has seen employees of 171 other companies achieving higher income per employee. While Intra Cellular Therapies Inc 's total ranking has deteriorated compared to the previous quarter from 468 to 4034.


What is Income per Employee Ratio?






ITCI Net Income per Employee (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -369,683 -427,574 -417,347 -548,851 -691,455
ITCI's Total Ranking # 4034 # 468 # 1548 # 1242 # 2249
Seq. Net Income Change - - - - -


ITCI Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 172
Healthcare Sector # 516
Overall Market # 4034

Net Income per Employee Statistics
High Average Low
$ -116,501 $ -755,774 $ -1,590,911
(Sep 30 2014)   (Jun 30 2022)







Companies with similar Income per Employee for 12 month ending Dec 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2024Number of Employees Dec 31 2024


Date modified: 2026-06-22T16:30:35+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.